Open Field Capital is a New York-based SEC-registered investment adviser established in 2003, focused on managing emerging technology portfolios across public equity and venture investments. The firm targets high-growth disruptive technology companies through a flexible, crossover mandate.
40% of their portfolio is in Consumer. Their most common stage is series-b (60% of deals). Average disclosed round size is $151.7M (across 3 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| EEridu AI | Unknown | $200M | Jan 2026 |
| DDelfi Diagnostics, Inc. | Series B | — | Jul 2022 |
 Delfi | Series B | — | Jul 2022 |
 Neo Cybernetica | Seed | $30M | Feb 2022 |
| Delfi | Series B | $225M | Jan 2022 |
Top Co-Investors
Osage University Partners4 shared
Cowen Healthcare Investments3 shared
Northpond Ventures3 shared
Illumina Ventures3 shared
Menlo Ventures3 shared
T. Rowe Price3 shared
OrbiMed3 shared
AV8 Ventures3 shared
Windham Capital Partners3 shared
Samsara BioCapital3 shared
Foresite Capital3 shared
Rock Springs Capital3 shared
Eli Lilly and Company3 shared
DFJ Growth2 shared
New Enterprise Associates1 shared
B Capital1 shared
Cortical Ventures1 shared
MediaTek1 shared
Chamaeleon1 shared
Godfrey Capital1 shared
Last updated: 9 September 2026